Range
42.2 - 43.71
Vol / Avg.
385.9K/114.8K
Div / Yield
-
52 Wk
36.48 - 53.43
Mkt Cap
562.7M
Payout Ratio
-
Open
42.97
P/E
40.85
EPS
-0.03
Shares
13.1M
Outstanding
13.1M
Total Float
7.9M
load more
Sector: Health Care.Industry: Biotechnology
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS0.6500.240 -0.4100
REV45.410M41.249M-4.161M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EGRXEagle Pharmaceuticals-1.27%562.7M

Eagle Pharmaceuticals Frequently Asked Questions

Q

How do I buy Eagle Pharmaceuticals (EGRX) stock?

A

You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Eagle Pharmaceuticals's (EGRX) competitors?

Q

What is the target price for Eagle Pharmaceuticals (EGRX) stock?

A

The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Cantor Fitzgerald on March 2, 2020. The analyst firm set a price target for 46.00 expecting EGRX to rise to within 12 months (a possible 7.25% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Eagle Pharmaceuticals (EGRX)?

A

The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $42.89 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Eagle Pharmaceuticals (EGRX) pay a dividend?

A

There are no upcoming dividends for Eagle Pharmaceuticals.

Q

When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?

A
Eagle Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Eagle Pharmaceuticals (EGRX) going to split?

A

There is no upcoming split for Eagle Pharmaceuticals.

Q

What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?

A

Eagle Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.